![Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease | Request PDF Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease | Request PDF](https://i1.rgstatic.net/publication/337095342_Glomerular_filtration_rate_by_differing_measures_albuminuria_and_prediction_of_cardiovascular_disease_mortality_and_end-stage_kidney_disease/links/5dc4f824299bf1a47b1fa576/largepreview.png)
Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease | Request PDF
![IMPRES does not reproducibly predict response to immune checkpoint blockade therapy in metastatic melanoma. - Nat. Med. - X-MOL IMPRES does not reproducibly predict response to immune checkpoint blockade therapy in metastatic melanoma. - Nat. Med. - X-MOL](https://xpic.x-mol.com/20191206%2F10.1038_s41591-019-0671-4.png)
IMPRES does not reproducibly predict response to immune checkpoint blockade therapy in metastatic melanoma. - Nat. Med. - X-MOL
![Metagenomic Analysis of Colorectal Cancer Datasets Identifies Cross-cohort Microbial Diagnostic Signatures and a Link with Choline Degradation | Request PDF Metagenomic Analysis of Colorectal Cancer Datasets Identifies Cross-cohort Microbial Diagnostic Signatures and a Link with Choline Degradation | Request PDF](https://i1.rgstatic.net/publication/332137786_Metagenomic_Analysis_of_Colorectal_Cancer_Datasets_Identifies_Cross-cohort_Microbial_Diagnostic_Signatures_and_a_Link_with_Choline_Degradation/links/5ca37f40a6fdcc12ee8ec36b/largepreview.png)
Metagenomic Analysis of Colorectal Cancer Datasets Identifies Cross-cohort Microbial Diagnostic Signatures and a Link with Choline Degradation | Request PDF
![Nature Medicine on Twitter: Nature Medicine on Twitter:](https://pbs.twimg.com/media/EJRN1ByXsAIjTKU.png)
Nature Medicine on Twitter: "Analysis of data from over 400,000 UK Biobank participants shows that glomerular filtration rate measured by cystatin C, but not serum creatinine, is strongly associated with #cardiovascular disease
![What a massive database of retracted papers reveals about science publishing's 'death penalty' | Science | AAAS What a massive database of retracted papers reveals about science publishing's 'death penalty' | Science | AAAS](https://www.sciencemag.org/sites/default/files/styles/article_main_large/public/Science53-color-1%20horizontal.jpg?itok=GQb_KAEe)
What a massive database of retracted papers reveals about science publishing's 'death penalty' | Science | AAAS
![Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers.,Nature Medicine - X-MOL Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers.,Nature Medicine - X-MOL](https://xpic.x-mol.com/20200410%2F10.1038_s41591-020-0800-0.png)
Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers.,Nature Medicine - X-MOL
![Uživatel Nature Medicine na Twitteru: „Toni Ribas @UCLA will next talk at #KSCancerImm about novel immune #checkpointblockade combos. He recently showed that treatment with anti-PD-1 or anti-PD-L1 agents produces a high response Uživatel Nature Medicine na Twitteru: „Toni Ribas @UCLA will next talk at #KSCancerImm about novel immune #checkpointblockade combos. He recently showed that treatment with anti-PD-1 or anti-PD-L1 agents produces a high response](https://pbs.twimg.com/media/D1jOzbXX4AEcBoM.png)
Uživatel Nature Medicine na Twitteru: „Toni Ribas @UCLA will next talk at #KSCancerImm about novel immune #checkpointblockade combos. He recently showed that treatment with anti-PD-1 or anti-PD-L1 agents produces a high response
![Nature Medicine در توییتر Nature Medicine در توییتر](https://pbs.twimg.com/media/EBTbxZDXkAAWLlV.jpg)
Nature Medicine در توییتر "First up from 2018: #Neoadjuvant combination treatment with nivolumab and ipilimumab in patients with high-risk #melanoma results in higher response rates than nivolumab monotherapy #NMEDClinical | https://t.co/QpHRjqbFdk ...
![Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes | Nature Medicine Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes | Nature Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-020-1008-z/MediaObjects/41591_2020_1008_Fig1_HTML.png)